Delivery Order SPE2DB20D1100-SPE2DB25FD6E0
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Fluticasone Propionate HFA 220 micrograms in 12-gram inhalers, with a ceiling value of $3,278.52. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 13, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 mcg inhalers (10.6 gm) valued at $2,799.78 on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitive award under the company's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Fluticasone Propionate HFA 110 MCG inhalers (12 GM units) with a ceiling value of $1,561.88. This competitively awarded, firm fixed-price delivery order is set to be completed by July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under a larger federal contract vehicle,...
- The Defense Logistics Agency awarded a $4,535.86 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 220 MCG inhalers (12 grams). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,451.00 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 44 MCG 10.6GM inhalers. This contract, which was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a firm fixed-price delivery order executed without a set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's Corporate Office...
- The Defense Logistics Agency awarded a delivery order valued at $4,875.39 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in 10.6-gram inhalers. This contract employs firm fixed price pricing and was competitively awarded without a set-aside designation. The order was placed on August 21, 2025, with an ultimate completion date of August 22, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler, with a ceiling value of $1,450.61. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of April 25, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $2,108.90 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Fluticasone Propionate HFA 110 mcg inhalers (12 grams), with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,719.68 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 44 micrograms in a 10.6-gram inhaler, with delivery performance required by August 6, 2025. This competitive award employs a firm fixed price model and represents a non-set-aside procurement executed on August 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a ceiling value of $1,504.06. This firm fixed-price delivery order, which was competitively awarded without a set-aside designation, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework. The contract specifies Conshohocken, Pennsylvania as the place of...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6E0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Fluticasone Propionate HFA 44 MCG inhalers (10.6 grams) at a firm fixed price of $3,186.32. This non-set-aside contract represents a competitive award to support federal medical procurement needs and is classified as a child contract, indicating it falls under a larger contract vehicle. The place of performance is the company's Conshohocken, Pennsylvania facility, with an ultimate completion date of July 25, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, encompassing a wide range of pharmaceuticals, generic medications, vaccines, and medical supplies. AmerisourceBergen's receipt of this award demonstrates its continued capability to fulfill federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 7/24/25 |